Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2010
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010074947A1 Amino pyrazole compound
07/01/2010WO2010074607A2 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
07/01/2010WO2010074480A2 Novel pyrazolodiazepine compounds as a transglutaminase inhibitor, the preparation method thereof and a composition containing the same
07/01/2010WO2010074284A1 Pyrazolopyrimidine compound
07/01/2010WO2010073660A1 Lead, wiring member, package part, metal part provided with resin and resin-sealed semiconductor device, and methods for producing same
07/01/2010WO2010072301A1 3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo [4,3-b] pyridazine derivatives
07/01/2010WO2010033981A3 5-azaindole bisphosphonates
07/01/2010WO2010030983A3 Pyrazole carboxamide inhibitors of factor xa
07/01/2010WO2010030785A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease
07/01/2010US20100168439 Self-assembled polyhedra
07/01/2010US20100168424 Fused heterocyclic derivative and use thereof
07/01/2010US20100168416 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/01/2010US20100168141 Azetidine analogues nucleosidase and phosphorylase inhibitors
07/01/2010US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta
07/01/2010US20100168138 Anti-Viral Compounds
07/01/2010US20100168136 Alkylsulfone derivatives
07/01/2010US20100168123 Akt protein kinase inhibitors
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168095 Multi-cyclic cinnamide derivatives
07/01/2010US20100168091 Imidazole Amines As Inhibitors Of Beta-secretase
07/01/2010US20100168082 Heterobicyclic Carboxamides as inhibitors for kinases
07/01/2010US20100167995 Peptoid compounds
07/01/2010US20100167931 Heterocyclically substituted heterocyclylcarboxylic acid derivatives
07/01/2010US20100167289 Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
07/01/2010US20100166819 Transforming Growth Factor Modulators
07/01/2010US20100166706 Hcv ns-3 serine protease inhibitors
07/01/2010DE102008063667A1 3-(3-Pyrimidin-2-yl-benzyl)-°[1,2,4]triazolo[4,3-b]pyrimidin-derivate 3- (3-pyrimidin-2-yl-benzyl) - ° [1,2,4] triazolo [4,3-b] pyrimidine derivatives
07/01/2010CA2747932A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
07/01/2010CA2744714A1 Amino pyrazole compound
06/2010
06/30/2010EP2201840A1 Inhibitors of Bruton's Tyrosine Kinase
06/30/2010EP2201013A2 New 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
06/30/2010EP2201012A1 Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors
06/30/2010EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
06/30/2010EP2200437A1 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
06/30/2010EP2066674B1 Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents
06/30/2010EP1943216B1 Prolinamide derivatives as sodium channel modulators
06/30/2010EP1618107B1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists
06/30/2010EP1599480B1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments
06/30/2010EP1411927B1 Method for the preparation of selectively-substituted corroles and new substituted corroles
06/30/2010EP1366760B1 Tablets quickly disintegrated in oral cavity
06/30/2010CN101765602A 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
06/30/2010CN101765601A 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof
06/30/2010CN101765600A pyrazolopyrimidinone kinase inhibitor
06/30/2010CN101765442A organic compounds
06/30/2010CN101759701A Preparation method of novel porphyrin
06/30/2010CN101759700A Method for synthesizing triethylene diamine (TEDA) by using ethylenediamine
06/30/2010CN101759699A Pyrro-perhydroazepinone compound and application thereof in preparing medicaments for treating tumors
06/30/2010CN101759645A P38 inhibitors and methods of use thereof
06/29/2010US7745620 End functional groups that can covalently bind with a solid substrate or a biochemical compounds to obtain a cucurbituril; chromatographic columns, additives to gas separation membranes, catalysts, chemical, biological sensors
06/29/2010US7745619 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease
06/29/2010US7745618 Method of making porphyrins
06/29/2010US7745473 Indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug containing the derivative
06/29/2010US7745451 2,3-Difluoro-benzyl)-[6-(5-methyl-pyridin-2-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yl]-amine, useful for the prevention and treatment of pain, inflammation, cognitive disorders, anxiety and depression in humans
06/29/2010US7745450 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases
06/29/2010US7745446 such as 4-Aminomethyl-N-[4-(5-biphenyl-4-yl-pyrazolo[1,5-c]pyrimidin-7-ylamino)-phenyl]-benzamide, useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis
06/29/2010US7745436 Disalt inhibitors of IL-12 production
06/29/2010US7745434 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration
06/29/2010US7745433 2-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2, 3-D] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
06/29/2010CA2442061C Process for preparing 4,6-diaminopyrimido[5,4-d]pyrimidines
06/29/2010CA2333986C Catalytic cracking process using an mcm-68 catalyst
06/24/2010WO2010071885A1 Pyrrolotriazines as alk and jak2 inhibitors
06/24/2010WO2010071846A2 Compounds for treating neuropsychiatric conditions
06/24/2010WO2010070318A1 Process for the preparation of anagrelide and analogues
06/24/2010WO2010070238A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
06/24/2010WO2010070237A1 Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
06/24/2010WO2010070004A1 Process for making a crystalline zilpaterol salt
06/24/2010WO2010069684A1 Compounds for treatment of duchenne muscular dystrophy
06/24/2010WO2010069441A1 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
06/24/2010WO2010022201A3 Folinic acid derivatives for promoting bone growth
06/24/2010WO2009155527A3 Phosphatidylinositol 3 kinase inhibitors
06/24/2010US20100160356 Novel cyclobutyl compounds as kinase inhibitors
06/24/2010US20100160350 Pyrazolopyrimidinone kinase inhibitor
06/24/2010US20100160349 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
06/24/2010US20100160346 Neurologically active compounds
06/24/2010US20100160345 Novel compounds
06/24/2010US20100160344 Novel compounds
06/24/2010US20100160330 Novel bicyclic heterocycles useful as selective androgen receptor modulators
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160311 Fungicidal Azolopyrimidines, Process for Their Preparation and Their Use For Controlling Harmful Fungi, and Also Compositions Comprising Them
06/24/2010US20100160291 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
06/24/2010US20100160255 Spiro-cyclic compound
06/24/2010US20100160163 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method for controlling weed with the same
06/24/2010DE102008062825A1 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo [4,3-b]pyridazin-derivate 3- (3-pyrimidin-2-yl-benzyl) - [1,2,4] triazolo [4,3-b] pyridazine derivatives
06/24/2010CA2747365A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
06/24/2010CA2747359A1 Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
06/24/2010CA2747331A1 Process for making a crystalline zilpaterol salt
06/24/2010CA2747287A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyrimidine derivatives
06/24/2010CA2746145A1 Process for the preparation of anagrelide and analogues
06/23/2010EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
06/23/2010EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors
06/23/2010EP2197882A2 Method for producing teda derivatives
06/23/2010EP2197881A1 Process for the manufacture of bridged monobactam intermediates
06/23/2010EP2197880A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
06/23/2010EP2197873A1 Compounds and compositions as modulators of gpr119 activity
06/23/2010EP2197855A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof
06/23/2010EP2197442A1 Polo-like kinase inhibitors
06/23/2010EP1646629B1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
06/23/2010CN1993130B Processes and intermediates used for preparing fused heterocyclic kinase inhibitors
06/23/2010CN1906173B Protein modifier production inhibitor